Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Early Extubation in Agitated ICU Patients
NCT05264077Phase 1Not yet recruiting
- Sponsor
- Sheikh Zayed Medical College
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of dexmedetomidine in agitation (2 arms), sponsored by Sheikh Zayed Medical College. Primary endpoint: Effective sedation leading to successful weaning at 48 hours. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
agitation
Beyond the preview
Go deeper on NCT05264077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264077.